The concentration of myocardial cyclic AMP was measured in 9 dogs by radioimmunoassay after the administration of aminophylline. Fourteen dogs served as control. The concentration of cyclic AMP in the left ventricle was the highest and the lowest value was obtained in the right atrium in the control dogs. Ventricular fibrillations were induced immediately after the injection of 30mg/Kg aminophylline in 3 dogs out of 9. The concentration of the left ventricular cyclic AMP in 6 dogs which tolerated aminophylline was significantly elevated compared with that of the control dogs (p<0.05). The left ventricular cyclic AMP in 3 dogs with ventricular fibrillation was significantly higher compared with that in the aminophylline tolerated dogs with non-fibrillating hearts (p<0.01).
SUMMARY
The concentration of myocardial cyclic AMP was measured in 9 dogs by radioimmunoassay after the administration of aminophylline. Fourteen dogs served as control. The concentration of cyclic AMP in the left ventricle was the highest and the lowest value was obtained in the right atrium in the control dogs. Ventricular fibrillations were induced immediately after the injection of 30mg/Kg aminophylline in 3 dogs out of 9. The concentration of the left ventricular cyclic AMP in 6 dogs which tolerated aminophylline was significantly elevated compared with that of the control dogs (p<0.05). The left ventricular cyclic AMP in 3 dogs with ventricular fibrillation was significantly higher compared with that in the aminophylline tolerated dogs with non-fibrillating hearts (p<0.01).
These results showed that the concentration of cyclic AMP was elevated in the fibrillating heart. inhibitor of phosphodiesterase and it happened that ventricular fibrillation was induced in some of the experimental animals soon after injection of aminophylline. In this paper, the concentration of myocardial cyclic AMP of dogs with ventricular fibrillation induced by aminophylline is reported. 
MATERIALS AND METHODS

RESULTS
The concentration of cyclic AMP in the heart of normal dogs: Table I shows the mean concentration of cyclic AMP in the heart of 8 dogs. The concentration in the left ventricle was the highest and the lowest was in the right atrium. 
DISCUSSION
In the present study, the concentration of the left ventricular cyclic AMP and the max dp/dt were increased after the injection of aminophylline. It was interesting that ventricular fibrillation was induced in some of the dogs soon after the administration of aminophylline and the concentration of the myocardial cyclic AMP in these dogs was significantly higher than that in the animals which survived after aminophylline. Podzuweit et al3) proposed that the development of ventricular fibrillation in ischemic heart disease and myocardial infarction could be related to accumulation of cyclic AMP in the ischemic zone. Horowitz et al4) demonstrated that aminophylline exerted a biphasic effects on the ventricular myocardium with regard to vulnerability to fibrillation. Within 5min after the start of infusion, the ventricular fibrillation threshold was decreased by 30 to 35%, the earliest measurable decrease occuring 4min after the onset of infusion. During the early phase of infusion of aminophylline, ventricular fibrillation could be induced more easily than before the infusion. After the completion of intravenous infusion, aminophylline exerts a protective effects on the myocardium by reducing the ease with which fibrillation can be initiated. The mechanism by which aminophylline produces the effects on ventricular fibrillation threshold is speculative. The effects of epinephrine on ventricular fibrillation threshold closely parallel that of aminophylline. Han et al5) in explainning the biphasic effects of epinephrine postulated that this agents, when administered intravenously, was initially distributed nonuniformely within the myocardium. A similar nonuniform distribution of aminophylline within the myocardium would be expected to enhance disparity between the time course of recovery of neighboring ventricular fibers. This increased temporal dispersion of recovery predisposes to reentry and fractionation of depolarization wave fronts, thereby facilitating the initiation of ventricular fibrillation.6)
The posipositive inotropic response of aminophylline, an inhibitor of phosphodiesterase, is similar to that of catecholamine. Its effects on contractility are mimicked by exposure of myocardium to derivatives of cyclic AMP such as dibutyryl cyclic AMP which resist degradation by phosphodiesterase. Lubbe et al7) reported that dibutyryl cyclic 3', 5'-AMP enhanced ventricular vulnerability to fibrillation by lowering the ventricular fibrillation threshold and increasing the duration of the vulneable periods. Ischemia,8) catecholamine,9) and aminophylline4) reduced the ventricular fibrillation threshold and are thought to provoke an intracellular accumulation of cylic AMP. Mori10) reported that adenyl cyclase activity in the infarcted area was significantly increased when compared with the non-infarcted area at 15min and this 
